Sun Pharma plans $11.75 billion acquisition of Organon
after close1 source ↓written by the desknot a recommendation
- deal
- $11.75 billion
Sun Pharmaceutical Industries is set to acquire Organon & Co. in a $11.75 billion deal. Legal support comes from AZB & Partners, Cyril Amarchand Mangaldas, and others, ensuring compliance with industry nuances. This acquisition may enhance Sun Pharma's portfolio and market position in the pharmaceutical sector. 📈
• Key legal advisors: AZB & Partners, Cyril Amarchand Mangaldas
• Transaction value: $11.75 billion
• Market implications: Potential growth in pharmaceutical offerings.
Not investment advice. For informational purposes only.